Marathon Trading Investment Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,200
Closed -$697K 322
2025
Q1
$697K Buy
4,200
+2,100
+100% +$329K 0.09% 112
2024
Q4
$304K Buy
2,100
+1,500
+250% +$232K 0.02% 183
2024
Q3
$97.2K Buy
+600
New +$95.6K 0.01% 227
2024
Q1
Sell
-7,100
Closed -$1.11M 419
2023
Q4
$1.11M Buy
7,100
+300
+4% +$46K 0.06% 164
2023
Q3
$1.06M Sell
6,800
-400
-6% -$66K 0.09% 101
2023
Q2
$1.19M Buy
7,200
+1,500
+26% +$242K 0.1% 85
2023
Q1
$884K Buy
5,700
+5,600
+5,600% +$904K 0.06% 110
2022
Q4
$17.7K Sell
100
-4,100
-98% -$708K ﹤0.01% 250
2022
Q3
$686K Sell
4,200
-600
-13% -$102K 0.07% 132
2022
Q2
$852K Buy
4,800
+2,200
+85% +$392K 0.1% 129
2022
Q1
$461K Buy
+2,600
New +$442K 0.04% 182
2021
Q1
Sell
-14,000
Closed -$2.2M 449
2020
Q4
$2.2M Buy
+14,000
New +$2.07M 0.11% 98
2017
Q1
Sell
-2,500
Closed -$288K 180
2016
Q4
$288K Buy
+2,500
New +$289K 0.03% 115

Other funds holding JNJ

Marathon Trading Investment Management's JNJ Position: Q4 2024 in Review

Marathon Trading Investment Management sold out of Johnson & Johnson (JNJ) in Q4 2024, closing a stake of 244 shares — an estimated $37.8K sold.

Marathon Trading Investment Management first reported a position in JNJ in Q4 2018 and held it in 4 quarters. The position peaked at $918K in Q4 2018. 4,108 funds tracked by Wall St. Rank hold JNJ as of Q4 2024.

  • Marathon Trading Investment Management reported no remaining Johnson & Johnson position as of Q4 2024 after selling out during the quarter.
  • Marathon Trading Investment Management sold 244 Johnson & Johnson shares in Q4 2024, an estimated $37.8K.
  • Marathon Trading Investment Management first reported a position in Johnson & Johnson in Q4 2018 and held it in 4 quarters.
  • Marathon Trading Investment Management's Johnson & Johnson position peaked at $918K in Q4 2018.
  • 4,108 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2024.

Based on Marathon Trading Investment Management's 13F filing for Q4 2024, filed 7 Feb 2025.